Adrenocorticotropic hormone (ACTH) producing pheochromocytoma is the rare cause of Cushing's syndrome (CS). Herein, we present a 53-year-old female patient with ectopic ACTH-dependent Cushing's syndrome due to pheochromocytoma. ACTH secreting pheochromocytoma is a rare but important source of ectopic ACTH secretion. Early diagnosis of pheochromocytoma with CS needs a high index of suspicion. The scenario provides clues for a detailed discussion about the pitfalls and diagnostic difficulties in establishing the underlying cause of ACTH-dependent CS. It demonstrates relative contributions of clinical, biochemical, and radiological clues in arriving at the correct underlying cause of CS.
INTRODUCTION
Cushing syndrome may be due to ectopic secretion of adrenocorticotropic hormone (ACTH) from bronchial carcinoid, islet cell tumor, small cell lung carcinoma, medullary carcinoma of the thyroid, thymic carcinoid, disseminated neuroendocrine tumor and disseminated gastrointestinal carcinoid. Cushing syndrome due to ACTH-secreting pheochromocytomas have sporadically been reported in the literature and accounts for 3% of ectopic ACTH-dependent Cushing syndrome. [1] We are reporting a case of ACTH-secreting pheochromocytoma presenting as Cushing's syndrome (CS).
The case provides clues for a detailed discussion on the pitfalls and diagnostic difficulties in establishing the correct underlying cause of ACTH-dependent CS. In addition, we review the literature concerning ACTH-producing pheochromocytomas.
CASE REPORT
A 53-year-old female known diabetic and hypertensive for 7 years presented to casualty with recurrent hypoglycemic attacks, hypokalemia, metabolic alkalosis, and labile hypertension with incidental ultrasonography finding of the right adrenal mass which was confirmed with contrast-enhanced computed tomography with dimensions of 4 cm × 3.8 cm × 3.3 cm mass associated with calcifications. On further evaluation in our hospital renal Doppler was normal, aldosterone-renin ratio -17.1 (n < 30), 24 h urinary cortisol was 22153.92 µg/24 h (28.50-213.70), overnight dexamethasone suppression test was 146.50 µg/dl (n < 1.8), CS confirmed with low dose dexamethasone suppression test 188.71 µg/dl (n < 1.8), serum ACTH 375 pg/mL (10-60 pg/mL) indicating ACTH-dependent Cushing's syndrome due to adrenocorticotropic hormone-secreting pheochromocytoma CS, 24 h urinary metanephrine was 3737.23 µg/g (27-155), and 24 h urinary normetanephrine was 1169.62 µg/g (46-256). Other relevant investigations were within normal range. In view of these investigations diagnosis of ACTH-dependent CS and pheochromocytoma was made and further evaluated for its etiology.
To detect the source of ACTH, magnetic resonance imaging brain [ Figure 3 ] with pituitary-specific dynamic contrast enhanced study was done which was normal. 
DISCUSSION
This case represents a very rare cause of ectopic CS caused by an ACTH-producing pheochromocytoma and illustrates the diagnostic challenges of ACTH-dependent CS and pheochromocytoma. CS comprises a large group of signs and symptoms that reflect prolonged and inappropriately high exposure of tissue to glucocorticoids. Endogenous CS is an uncommon disorder with an incidence of 2-3 cases per 1 million inhabitants per year with 10% being ectopic. In rare cases, ACTH-producing phaeochromocytomas (3%) are the cause of Cushing syndrome. [1] [2] [3] The prevalence of pheochromocytoma in patients with hypertension in the general outpatient clinics varies between 0.2 and 0.6%, and autopsy studies demonstrate undiagnosed tumors in 0.05-0.1% of patients. [4, 5] Pheochromocytoma is a challenging and life-threatening tumor, often associated with very difficult to interpret clinical manifestations. This neoplasm may secrete various substances such as somatostatin, encephalin, calcitonin, vasoactive intestinal peptide, neuropeptide Y, renin, ACTH, parathyroid hormone, erythropoietin, adrenomedullin, and dihydroxyphenylalanine in addition to catecholamines. The symptoms manifested by the patients depend on the prevailing secretory products secreted from the tumor. [6] [7] [8] 
E c t o p i c CS c a u s e d b y AC T H -p r o d u c i n g
pheochromocytoma has been reported in only 24 patients and was first described by Meloni in 1966. [9] Remarkably, 21 of these 24 patients were women, and almost all presented with large adrenal tumors (2-6 cm).
ACTH produced by the tumor stimulates the adrenal cortex to hyper-secrete cortisol. Hence, as in our patient, the prevalent clinical manifestation is a CS. Many other tumors, such as small-cell lung carcinoma, bronchial carcinoid, and medullary carcinoma of the thyroid, have been found to be associated with ectopic ACTH secretion. These candidate tumors were ruled out in the present case.
Despite the unusual presentation of pheochromocytoma as Cushing syndrome, the prognosis is similar to the conventional pheochromocytomas. After removal of the ACTH-secreting adrenal tumor, the patient develops transient hypocortisolism. This is explained by the feedback inhibition of the cortisol-secreting tumor on ACTH secretion from the pituitary. After adrenalectomy, the pituitary recovers from the feedback inhibition and normal cortisol level is restored. ACTH secreting pheochromocytomas are the exception to the rule; unilateral adrenalectomy is curative, and the contralateral hyperplastic adrenal can be preserved. This approach results in resolution of both syndromes of hormone excess and preserves long-term adrenal function. [8] Final diagnosis can be confirmed with immunohistochemistry for ACTH and chromogranin.
CONCLUSION
Cushing syndrome can be a rare presentation of pheochromocytoma as a result of ectopic secretion of ACTH. It is often difficult to diagnose this presentation preoperatively, especially in cases with a predominant secretion of ACTH rather than catecholamines. In such cases, the final diagnosis can be made only by IHC analysis. An ACTH secreting pheochromocytoma should be one of the differential diagnoses in patients with adrenal mass and elevated ACTH levels.
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